.

Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Identify first generic entrants
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Queensland Health
Medtronic
UBS
McKesson
Deloitte
AstraZeneca
Cipla
Chubb
Cantor Fitzgerald
Argus Health

Generated: June 26, 2017

DrugPatentWatch Database Preview

ASPIRIN AND DIPYRIDAMOLE Drug Profile

« Back to Dashboard

Which patents cover Aspirin And Dipyridamole, and what generic Aspirin And Dipyridamole alternatives are available?

Aspirin And Dipyridamole is a drug marketed by Barr, Sandoz Inc, Par Pharm Inc, Impax Labs Inc, and Amneal Pharms. and is included in five NDAs.

The generic ingredient in ASPIRIN AND DIPYRIDAMOLE is aspirin; dipyridamole. There are twenty-one drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the aspirin; dipyridamole profile page.

Summary for Tradename: ASPIRIN AND DIPYRIDAMOLE

Patents:0
Applicants:5
NDAs:5
Suppliers / Packagers: see list4
Clinical Trials: see list104,428
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:ASPIRIN AND DIPYRIDAMOLE at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Barr
ASPIRIN AND DIPYRIDAMOLE
aspirin; dipyridamole
CAPSULE, EXTENDED RELEASE;ORAL078804-001Aug 14, 2009ABRXNoNo► Subscribe► Subscribe
Impax Labs Inc
ASPIRIN AND DIPYRIDAMOLE
aspirin; dipyridamole
CAPSULE, EXTENDED RELEASE;ORAL206964-001Jan 18, 2017ABRXNoNo► Subscribe► Subscribe
Sandoz Inc
ASPIRIN AND DIPYRIDAMOLE
aspirin; dipyridamole
CAPSULE, EXTENDED RELEASE;ORAL206739-001Jan 18, 2017ABRXNoNo► Subscribe► Subscribe
Par Pharm Inc
ASPIRIN AND DIPYRIDAMOLE
aspirin; dipyridamole
CAPSULE, EXTENDED RELEASE;ORAL207944-001Jan 18, 2017ABRXNoNo► Subscribe► Subscribe
Amneal Pharms
ASPIRIN AND DIPYRIDAMOLE
aspirin; dipyridamole
CAPSULE, EXTENDED RELEASE;ORAL206392-001Mar 8, 2016ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Covington
UBS
Farmers Insurance
Boehringer Ingelheim
Harvard Business School
US Army
US Department of Justice
Colorcon
Teva
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot